Cargando…
Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531363/ https://www.ncbi.nlm.nih.gov/pubmed/33082643 http://dx.doi.org/10.4103/iju.IJU_193_20 |
| _version_ | 1783589750192472064 |
|---|---|
| author | Ranjan, Satish Kumar |
| author_facet | Ranjan, Satish Kumar |
| author_sort | Ranjan, Satish Kumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7531363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75313632020-10-19 Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? Ranjan, Satish Kumar Indian J Urol Uroscan Wolters Kluwer - Medknow 2020 2020-07-01 /pmc/articles/PMC7531363/ /pubmed/33082643 http://dx.doi.org/10.4103/iju.IJU_193_20 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Uroscan Ranjan, Satish Kumar Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title | Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title_full | Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title_fullStr | Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title_full_unstemmed | Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title_short | Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer? |
| title_sort | lutetium-177 prostate-specific membrane antigen-617 theranostics: new therapeutic hope in metastatic castrate-resistant prostate cancer? |
| topic | Uroscan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531363/ https://www.ncbi.nlm.nih.gov/pubmed/33082643 http://dx.doi.org/10.4103/iju.IJU_193_20 |
| work_keys_str_mv | AT ranjansatishkumar lutetium177prostatespecificmembraneantigen617theranosticsnewtherapeutichopeinmetastaticcastrateresistantprostatecancer |